Skip to main content

Hologic Value Stock - Dividend - Research Selection


ISIN: US4364401012 , WKN: 879100

Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health. It offers Aptima family of assays, target capture/nucleic acid extraction technology, transcription-mediated amplification technology, hybridization protection and dual kinetic assay technologies, instrumentation, Invader chemistry platform, ThinPrep system, and rapid fetal fibronectin test products. It also provides breast imaging and related products, and accessories comprising digital and film-based mammography systems; computer-aided detection for mammography; minimally invasive breast biopsy devices; breast biopsy site markers; and breast biopsy guidance systems. In addition, it offers Dimensions platform, a mammography gantry for 2D and tomosynthesis image acquisition and display; C-View and Intelligent 2D, a software product that provides 2D images; Selenia digital mammography platform; and SecurView Workstation. Further, it provides SculpSure, MonaLisa Touch, Vectus diode, and Cellulaze laser devices; PicoSure and Icon aesthetic systems; MedLite, RevLite, Cynergy, Elite, and SmartLipo products; and system components. Additionally, it offers NovaSure system to treat women suffering from abnormal uterine bleeding; MyoSure system for the hysteroscopic removal of fibroids; discovery and horizon X-ray bone densitometers that assess the bone density of fracture sites; and mini C-arm imaging systems to perform minimally invasive surgical procedures on a patient\'s extremities, such as the hand, wrist, knee, foot, and ankle. The company sells its products through direct sales and service forces, and a network of independent distributors and sales representatives. Hologic, Inc. was founded in 1985 and is headquartered in Marlborough, Massachusetts.
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Here's Why You Should Retain Abbott (ABT) Stock for Now

Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.

Hologic Inc. stock outperforms competitors despite losses on the day

Shares of Hologic Inc. slid 1.43% to $78.63 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...

Neogen (NEOG) Receives New Label Claims for Viroxide Super

Neogen's (NEOG) Viroxide Super active constituents are potassium peroxymonosulfate and sodium chloride, which have been verified effective against multiple industry-relevant bacteria and viruses.

Three Reasons to Add Masimo (MASI) Stock to Your Portfolio

Investors continue to be optimistic about Masimo (MASI) due to its focus on patient monitoring.

Chemed (CHE) Up on Roto-Rooter Sales Growth, Strong Admissions

Chemed (CHE) records increases in drain cleaning, plumbing, excavation and water restoration revenues within the Roto-Rooter branch commercial business.

HealthEquity (HQY) Beats on Q4 Earnings, Margins Rise

HealthEquity (HQY) witnesses solid growth in HSAs, alongside recording robust performances in all its segments, in the fourth quarter of fiscal 2023.

Hologic Inc. stock outperforms market on strong trading day

Shares of Hologic Inc. rallied 1.86% to $79.77 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...

Syneos Health's (SYNH) New Microsoft Deal to Expand AI Usage

With the multi-year deal, Syneos Health (SYNH) aims to deliver technology and data solutions with Microsoft.

Merit Medical's (MMSI) New Launch to Boost its Product Suite

Merit Medical's (MMSI) latest addition to its Vascular portfolio is expected to significantly enhance patient outcomes. featured highlights include AutoNation, Atkore, Valero Energy, Hologic and Ryder System

AutoNation, Atkore, Valero Energy, Hologic and Ryder System are part of the Zacks Screen of the Week article.